HDAC9 and cholangiocarcinoma: Kwak et al. reported that histone deacetylase (HDAC) inhibitor (vorinostat)-eluting stent effectively inhibits expression of HDAC, induces acetylated histone (Ac-histone), and then inhibits tumor growth in CCA cell-bearing mice model [17].